Epizyme, Inc. (EPZM)

[02opida]

CAMBRIDGE, Mass., May 7, 2014 /PRNewswire/ -- Epizyme, Inc. EPZM +0.01% , a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it will host a conference call and live audio webcast on Tuesday, May 13, 2014, at 4:30 p.m. ET to report first quarter 2014 financial results and provide a corporate update.

To participate in the conference call, please dial 1-877-844-6886 (domestic) or 1-970-315-0315 (international) and refer to conference ID 40579133. The live webcast can be accessed under "Events and Presentations" in the Investor Relations section of the Company's website at www.epizyme.com .